The recent research partnership between the University of Saskatchewan and the Neuroregeneration Research Institute of McLean Hospital* provides a glimmer of hope for patients suffering from Alzheimer’s disease and Parkinson’s disease. Stem cells are to be used to repair brain circuits through the production of dopamine, an essential chemical that is destroyed by the diseases. “The unique feature of this technology is the use of patients’ own stem cells. These cells from the skin or blood will be converted into brain cells. Once transplanted, they will do the rest,” explains Dr Ivar Mendez, leader of the brain regeneration programme.
* Located in Massachusetts, McLean Hospital is a Harvard Medical School affiliate
